FS Development Corp II - Ordinary Shares - Class A

0.00 (0.00%)
Debt Financing / Related, Mergers / Acquisitions, Equity Financing / Related

Pardes Biosciences And FS Development Corp. II Announce Merger Agreement

Published: 06/29/2021 10:15 GMT
FS Development Corp II - Ordinary Shares - Class A (FSII) - Pardes Biosciences and Fs Development Corp.
Ii Announce Merger Agreement Creating Publicly Listed Biopharmaceutical Company Advancing Oral Antiviral Drugs to Treat and Prevent Sars-cov-2 Infections.
Fs Development Ii Corp - Total Proceeds From Transaction Expected to Be Approximately $276 Million.
Fs Development Ii Corp - Combined Company is Expected to Be Listed on Nasdaq Under Ticker Symbol Prds.
Fs Development Ii Corp - a Group of Investors Committed to Participate in Transaction Through a Common Stock Pipe of About $75 Million at $10/share.